Article Information
History
- June 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Luis Antonio Peroni1,
- Jessica Toscaro1,3,
- Camila Canateli1,
- Gabriel Lima1,4,
- Ana Pagliarone3,
- Elaine Cardoso1,
- Renata Viana5,
- Jessica Bassani Borges5,
- Hui Tzu Lin-Wang5,
- Cely S. Abboud6,
- Carlos Gun5,
- Kleber Franchini1,3 and
- Marcio Bajgelman1,2,3,*
- 1Brazilian Biosciences National Laboratory, Center for Research in Energy and Materials, Campinas-SP, Brazil
- 2Faculty of Pharmaceutical Sciences, University of Campinas, Campinas-SP, Brazil
- 3Medical School, University of Campinas, Campinas-SP, Brazil
- 4Molecular Sciences undergrad program, University of São Paulo, São Paulo - SP, Brazil
- 5Research Division, Dante Pazzanese Cardiology institute, São Paulo-SP, Brazil
- 6Infectious Diseases Section and Hospital Infection Control Committee, Dante Pazzanese Cardiology Institute, São Paulo-SP, Brazil
- ↵*Correspondence should be addressed to Marcio Bajgelman, email marcio.bajgelman{at}lnbio.cnpem.br
Posted June 09, 2021.
Development of low-cost serological immunoassay to detect antiviral antibodies to Sars-Cov-2 Spike protein
